IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 11, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-30
DOI
10.1038/s41419-018-1143-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis
- (2018) K Furue et al. ACTA DERMATO-VENEREOLOGICA
- Interleukin-36 cytokine family signalling in hidradenitis suppurativa
- (2018) L. Emtestam et al. BRITISH JOURNAL OF DERMATOLOGY
- The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression
- (2018) Jennifer Palomo et al. PLoS One
- RNA-Seq Analysis of IL-1B and IL-36 Responses in Epidermal Keratinocytes Identifies a Shared MyD88-Dependent Gene Signature
- (2018) William R. Swindell et al. Frontiers in Immunology
- IL-36γ has proinflammatory effects on human endothelial cells
- (2017) Charlie Bridgewood et al. EXPERIMENTAL DERMATOLOGY
- Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities
- (2017) James G. Krueger et al. EXPERIMENTAL DERMATOLOGY
- Biology of IL-38 and its role in disease
- (2017) Frank L. van de Veerdonk et al. IMMUNOLOGICAL REVIEWS
- Regulation and function of interleukin-36 cytokines
- (2017) Esen Yonca Bassoy et al. IMMUNOLOGICAL REVIEWS
- β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
- (2017) Frank Kolbinger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pathogenesis of psoriasis and development of treatment
- (2017) Eisaku Ogawa et al. JOURNAL OF DERMATOLOGY
- Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells
- (2017) Sara Costa et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy
- (2017) Jing Zhang et al. Scientific Reports
- The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function
- (2017) Carolina M. Pfaff et al. Scientific Reports
- Distinct expression of interleukin (IL)-36α, βandγ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease
- (2016) M.-A. Boutet et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Imiquimod Increases Cutaneous VEGF Expression in Imiquimod-induced Psoriatic Mouse Model
- (2016) Hui-Hui Wu et al. Current Vascular Pharmacology
- Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1
- (2016) Seunghyun Jo et al. CYTOKINE
- Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines
- (2016) Damien Dietrich et al. CYTOKINE
- Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis and inflammation in keratinocytes and in mouse psoriatic model
- (2016) R Palombo et al. Cell Death & Disease
- Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses
- (2015) D. Wallach et al. BRITISH JOURNAL OF DERMATOLOGY
- Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin
- (2015) Maris Keermann et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- IL-36γ (IL-1F9) Is a Biomarker for Psoriasis Skin Lesions
- (2015) Angelo Massimiliano D'Erme et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions
- (2015) Cem Gabay et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Immunology of Psoriasis
- (2014) Michelle A. Lowes et al. Annual Review of Immunology
- IL-36 Promotes Myeloid Cell Infiltration, Activation, and Inflammatory Activity in Skin
- (2014) A. M. Foster et al. JOURNAL OF IMMUNOLOGY
- Inhibition of Inflammatory and Proliferative Responses of Human Keratinocytes Exposed to the Sesquiterpene Lactones Dehydrocostuslactone and Costunolide
- (2014) Claudia Scarponi et al. PLoS One
- Inhibition of Keratinocyte Differentiation by the Synergistic Effect of IL-17A, IL-22, IL-1α, TNFα and Oncostatin M
- (2014) Hanitriniaina Rabeony et al. PLoS One
- Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalk
- (2012) Luigi Tortola et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
- (2012) F. L. van de Veerdonk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis
- (2012) S Madonna et al. Cell Death & Disease
- Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis
- (2011) Alexandros Onoufriadis et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity
- (2011) Jennifer E. Towne et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis
- (2011) Yijun Carrier et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
- (2011) Slaheddine Marrakchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sirtinol Treatment Reduces Inflammation in Human Dermal Microvascular Endothelial Cells
- (2011) Angela Orecchia et al. PLoS One
- Pathobiology of Chronic Inflammatory Skin Diseases: Interplay Between Keratinocytes and Immune Cells as a Target for Anti-Inflammatory Drugs
- (2010) C. Albanesi et al. CURRENT DRUG METABOLISM
- STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation
- (2010) Rosanna Sestito et al. FASEB JOURNAL
- The IFN- -Dependent Suppressor of Cytokine Signaling 1 Promoter Activity Is Positively Regulated by IFN Regulatory Factor-1 and Sp1 but Repressed by Growth Factor Independence-1b and Kruppel-Like Factor-4, and It Is Dysregulated in Psoriatic Keratinocytes
- (2010) S. Madonna et al. JOURNAL OF IMMUNOLOGY
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
- (2009) L. van der Fits et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation